28
Participants
Start Date
September 15, 2024
Primary Completion Date
September 30, 2024
Study Completion Date
February 17, 2025
Hemay005
In the first cycle, 15mg (1 tablet/person) was given on an empty stomach for Hemay005-T1 or Hemay005-T2, and the second cycle was crossed over
Wuhan Central Hospital, Wuhan
Lead Sponsor
Ganzhou Hemay Pharmaceutical Co., Ltd
INDUSTRY